KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Change in Cash (2020 - 2025)

Clover Health Investments' Change in Cash history spans 6 years, with the latest figure at -$111.8 million for Q4 2025.

  • For Q4 2025, Change in Cash fell 19.63% year-over-year to -$111.8 million; the TTM value through Dec 2025 reached -$116.2 million, down 744.04%, while the annual FY2025 figure was -$116.2 million, 744.04% down from the prior year.
  • Change in Cash reached -$111.8 million in Q4 2025 per CLOV's latest filing, down from $1.4 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $312.2 million in Q1 2021 to a low of -$283.5 million in Q3 2021.
  • Average Change in Cash over 5 years is -$702350.0, with a median of $32.5 million recorded in 2024.
  • The largest YoY upside for Change in Cash was 3634.86% in 2021 against a maximum downside of 1503.41% in 2021.
  • A 5-year view of Change in Cash shows it stood at $97.7 million in 2021, then plummeted by 301.28% to -$196.7 million in 2022, then rose by 10.88% to -$175.2 million in 2023, then skyrocketed by 46.7% to -$93.4 million in 2024, then dropped by 19.63% to -$111.8 million in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Change in Cash are -$111.8 million (Q4 2025), $1.4 million (Q3 2025), and $33.2 million (Q2 2025).